uniQure N.V.·4

Jul 25, 3:19 PM ET

Kuta Alexander Edward III 4

4 · uniQure N.V. · Filed Jul 25, 2022

Insider Transaction Report

Form 4
Period: 2022-07-21
Kuta Alexander Edward III
Sr VP of Regulatory Affairs
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-07-21$5.31/sh+595$3,15995,791 total
  • Sale

    Ordinary Shares

    2022-07-21$25.00/sh595$14,87595,196 total
  • Exercise/Conversion

    Ordinary Shares

    2022-07-22$5.31/sh+5,643$29,964100,839 total
  • Sale

    Ordinary Shares

    2022-07-22$25.00/sh5,643$141,07595,196 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-07-2159543,405 total
    Exercise: $5.31Exp: 2027-01-23Ordinary Shares (595 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-07-225,64337,762 total
    Exercise: $5.31Exp: 2027-01-23Ordinary Shares (5,643 underlying)
Footnotes (3)
  • [F1]The transactions reported herein were effected pursuant to a sales plan dated March 3, 2021 adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]The Stock Option vested 25% on January 23, 2018 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.
  • [F3]Adjusted to correct a typographical error on the Reporting Person's last Form 4, pursuant to which the number of Ordinary Shares held after the reported transaction was inadvertently under-reported by 40 shares.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT